✦ LIBER ✦

A multicenter phase II study of epirubicin with low-dose trastuzumab as a first line treatment in Her-2 overexpressing metastatic breast cancer: preliminary results

✍ Scribed by M. Zilli; De Tursi; C. Carella; E. Ricevuto; P. Marchetti; A. Gennari; C. Orlandini; A. Frassoldati; P. Conte; S. Iacobelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P101 A multicenter phase II study of Epi

✍ M. De Tursi; C. Carella; E. Ricevuto; A. Gennari; C. Orlandini; A. Frassoldati; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

413 POSTER A multicenter phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Combination docetaxel and trastuzumab tr

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Efficacy and Safety of Trastuzumab as a

✍ Vogel, C. L. 📂 Article 📅 2002 🏛 American Society of Clinical Oncology 🌐 English ⚖ 88 KB

Weekly docetaxel and trastuzumab for her

✍ S Takao; N Kohno; M Miyashita; I Kokufu; K Wakita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB